Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$242,284
+$56,491 QoQ
Shares Held
202
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#4,307
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Graney & King, LLC holds $1,046,032 across 11 Drug Manufacturers - General names. LLY ranks #2 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,602 | $406,859 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
202 | $242,284 | |
| 3 | GSK |
GSK plc
|
2,485 | $130,263 | |
| 4 | ABBV |
AbbVie Inc.
|
365 | $91,848 | |
| 5 | AMGN |
Amgen Inc
|
150 | $54,318 | |
| 6 | PFE |
Pfizer Inc
|
1,856 | $44,692 | |
| 7 | MRK |
Merck & Co., Inc.
|
250 | $32,125 | |
| 8 | BIIB |
Biogen Inc.
|
106 | $22,902 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,284 | 202 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $185,793 | 202 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $217,085 | 202 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $138,866 | 182 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $141,094 | 181 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $130,493 | 158 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $111,940 | 145 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||